Symint™

Symint™

Products

Information

Symint™ was evaluated in-vitro internally in an intestinal cell line (HT-29) by the quantification of IL-8 production in response to a pro-inflammatory agent: lipopolysaccharide (LPS) from Pseudomonas aeruginosa. Symint™, decreased interleukin IL-8 production in a dose dependent manner. Compared to control, the highest dose of Symint™ induced a decrease of 78% of IL-8 production.
Ingredients
AntioxidantsBotanicals & Herbs
Groupe Berkem4D84Groupe Berkem, with 60 years of experience, is a leading expert in plant and marine extraction. The company has a strong presence in the cosmetics, dietary supplements, and agri-food industries. Dedicated to responsibly managing the entire plant-related value chain, its approach includes independent and premium raw material sourcing and innovative active ingredient development under regulatory and quality control. Groupe Berkem's nutraceutical range includes active ingredients from carefully selected plants known for their properties. With its in-house production facilities and R&D team, Groupe Berkem offers tailor-made solutions to meet specific customer needs.Groupe Berkem integrates nature intelligence into everyday life.

Join the event!

See all the content and easy-to-use features by logging in or registering!